Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

PLoS One · 2018 · PMC6283464 · PMID 30521571

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Furthermore, a marginally significant negative association between protein expression of EGFR using IHC and pathologic complete response (pCR) has been observed in 44 HER2-positive patients treated with trastuzumab-containing neo-adjuvant chemotherapy [ 40 ].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.